Development of chondroitin sulfate encapsulated PLGA microsphere delivery systems with controllable multiple burst releases for treating osteoarthritis

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 97 B, Issue 2, 2011, Pages 355-363

  Jiang, Tao ^a   Petersen, Rebecca R ^a   Call, Gazell ^a   Ofek, Gidon ^a   Gao, Jizong ^a   Yao, Jian Q ^a  

^a Zimmer Orthobiologics Inc   (United States)

Author keywords

chondroitin sulfate; microspheres; multiple burst releases; poly(lactide co glycolide)

Indexed keywords

BURST RELEASE; CHONDROITIN SULFATES; CYTOTOXIC; DELIVERY SYSTEMS; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION EFFICIENCY; ISO 10993; MICROSPHERE SIZES; MIXED TYPE; MULTIPLE BURST RELEASES; PLGA MICROSPHERES; POLY(LACTIDE-CO-GLYCOLIDE); THERAPEUTIC AGENTS;

CYTOTOXICITY; DRUG DELIVERY; ENCAPSULATION;

MICROSPHERES;

BLYSCAN; CHONDROITIN SULFATE; MICROSPHERE; POLYGLACTIN; UNCLASSIFIED DRUG;

ARTICLE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; MICROENCAPSULATION; OSTEOARTHRITIS;

BIOCOMPATIBLE MATERIALS; CHONDROITIN SULFATES; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; OSTEOARTHRITIS; PARTICLE SIZE; POLYGLYCOLIC ACID;

EID: 79953801777     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31822     Document Type: Article

References (33)

1. Ross MH, Pawlina W,. Histology: A Text and Atlas, 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
2. Mankin HJ, Grodzinsky AJ, Buckwalter JA,. Articular cartilage and osteoarthritis. In:, Einhorn TA, O'Keefe RJ, Buckwalter JA, editors. Orthopaedic Basic Science: Foundations of Clinical Practice, 3rd ed. Rosemont: AAOS; 2007. pp 161-174.
3. Osteoarthritis. Available at: (accessed 08/23/10).
4. Divine JG, Zazulak BT, Hewett TE,. Viscosupplementation for knee osteoarthritis: A systematic review. Clin Orthop Relat Res 2007; 455: 113-122. (Pubitemid 46213720)
5. Juni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B, Zullig M, Hauselmann HJ, Schwarz H, Theiler R, Ziswiler HR, Dieppe PA, Villiger PM, Egger M, Swiss Viscosupplementation Trial Group. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: A randomized controlled trial. Arthritis Rheum 2007; 56: 3610-3619. (Pubitemid 350100694)
6. Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N,. Treatment of primary and secondary osteoarthritis of the knee. Available at: (accessed 08/23/10).
7. Moller I, Perez M, Monfort J, Benito P, Cuevas J, Perna C, Domenech G, Herrero M, Montell E, Verges J,. Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: A randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage 2010; 18 (Suppl 1): S32-S40.
8. Kubo M, Ando K, Mimura T, Matsusue Y, Mori K,. Chondroitin sulfate for the treatment of hip and knee osteoarthritis: Current status and future trends. Life Sci 2009; 85: 477-483.
9. Bruyere O, Reginster JY,. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging 2007; 24: 573-580. (Pubitemid 47195676)
10. David-Raoudi M, Deschrevel B, Leclercq S, Galera P, Boumediene K, Pujol JP,. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. Arthritis Rheum 2009; 60: 760-770.
11. Iovu M, Dumais G, du Souich P, Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 2008; 16: S14-S18.
12. Pipitone VR,. Chondroprotection with chondroitin sulfate. Drugs Exp Clin Res 1991; 17: 3-7.
13. Jackson CG, Plaas AH, Sandy JD, Hua C, Kim-Rolands S, Barnhill JG, Harris CL, Clegg DO,. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. Osteoarthritis Cartilage 2010; 18: 297-302.
14. LaVan DA, McGuire T, Langer R,. Small-scale for in vivo drug delivery. Nat Biotechnol 2003; 21: 1184-1191.
15. Avgoustakis K,. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: Preparation, properties and possible applications in drug delivery. Curr Drug Deliv 2004; 1: 321-333.
16. DeFail AJ, Chu CR, Izzo N, Marra KG,. Controlled release of bioactive TGF-β1 from microspheres embedded within biodegradable hydrogels. Biomaterials 2006; 27: 1579-1585. (Pubitemid 41739583)
17. Rosas JE, Hernandez RM, Gascon AR, Igartua M, Guzman F, Patarroyo ME, Pedraz JL,. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine 2001; 19: 4445-4451. (Pubitemid 32718668)
18. Yang YY, Chung TS, Bai XL, Chan WK,. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem Eng Sci 2000; 55: 2223-2236.
19. Yamaguchi Y, Takenaga M, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R,. Insulin-loaded biodegradable PLGA microcapsules: Initial burst release controlled by hydrophilic additives. J Control Release 2002; 81: 235-249. (Pubitemid 34607145)
20. Wang YM, Sato H, Horikoshi I,. In vitro and in vivo evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres. J Control Release 1997; 49: 157-166. (Pubitemid 28020269)
21. Berkland C, King M, Cox A, Kim K, Pack DW,. Precise control of PLG microsphere size provides enhanced control of drug release rate. J Control Release 2002; 82: 137-147. (Pubitemid 34775055)
22. Raman K, Berkland C, Kim K, Pack DW,. Modeling small-molecule release from PLG microspheres: Effects of polymer degradation and nonuniform drug distribution. J Control Release 2005; 103: 149-158. (Pubitemid 40248569)
23. Lee ES, Park KH, Kang D, Park IS, Min HY, Lee DH, Kim S, Kim JH, Na K,. Protein complexted with chondroitin sulfate in poly(lactide-co-glycolide) microspheres. Biomaterials 2007; 28: 2754-2762. (Pubitemid 46420713)
24. Park W, Na K,. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pl value in poly(lactide-co-glycolide) microsphere for stability and controlled release. Colloids Surf B Biointerfaces 2009; 72: 193-200.
25. Huang X, Brazel CS,. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 2001; 73: 121-136. (Pubitemid 32539245)
26. Wang J, Wang BM, Schwendeman SP,. Characterization of the initial burst release of a model peptide from poly(D,L -lactide-co-glycolide) microspheres. J Control Release 2002; 82: 289-307. (Pubitemid 34880185)
27. Allison SD,. Analysis of initial burst in PLGA microspheres. Expert Opin Drug Deliv 2008; 5: 615-628. (Pubitemid 351998252)
28. Ho YC, Mi FL, Sung HW, Kuo PL,. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. Int J Pharm 2009; 376: 69-75.
29. He CL, Huang ZM, Han XJ,. Fabrication of drug-loaded electrospun aligned fibrous threads for suture applications. J Biomed Mater Res A 2009; 89: 80-95.
30. Berkland C, Kim K, Pack DW,. PLG microsphere size controls drug release rate through several competing factors. Pharm Res 2003; 20: 1055-1062. (Pubitemid 36774277)
31. Berchane NS, Carson KH, Rice-Richt AC, Andrews MJ,. Effect of mean diameter and polydispersity of PLG microspheres on drug release: Experiment and theory. Int J Pharm 2007; 337: 118-126. (Pubitemid 46756043)
32. Moioli EK, Hong L, Guardado J, Clark PA, Mao JJ,. Sustained release of TGFβ3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng 2006; 12: 537-546. (Pubitemid 43673459)
33. Ravivarapu HB, Burton K, DeLuca PP,. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur J Pharm Biopharm 2000; 50: 263-270.